nicorandil has been researched along with Ventricular Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charpie, JR; Deatrick, KB; Jeakle, M; Major, T; Mohammed, A; Peng, YW | 1 |
| Jahangir, A; Jahangir, R; López, JR; Shen, WK; Terzic, A | 1 |
2 other study(ies) available for nicorandil and Ventricular Dysfunction
| Article | Year |
|---|---|
Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass.
Topics: Adenosine Triphosphate; Animals; Cardiopulmonary Bypass; Humans; Inflammation; Myocardial Reperfusion Injury; Nicorandil; Nitric Oxide Donors; Oxidants; Potassium Channels; Rabbits; Saline Solution; Vasodilator Agents; Ventricular Dysfunction | 2022 |
Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia.
Topics: Adenosine Triphosphate; Aniline Compounds; Animals; Calcium; Calcium Channel Blockers; Cardioplegic Solutions; Cells, Cultured; Fluorescent Dyes; Glyburide; Guinea Pigs; Heart Arrest, Induced; Heart Ventricles; Hypertonic Solutions; Image Processing, Computer-Assisted; Ion Channel Gating; Microscopy, Confocal; Myocardium; Niacinamide; Nicorandil; Picolines; Potassium; Potassium Channel Blockers; Potassium Channels; Pyrans; Ventricular Dysfunction; Xanthenes | 1996 |